Guideline No. 393-Diabetes in Pregnancy

J Obstet Gynaecol Can. 2019 Dec;41(12):1814-1825.e1. doi: 10.1016/j.jogc.2019.03.008.

Abstract

Objectives: This guideline reviews the evidence relating to the diagnosis and obstetrical management of diabetes in pregnancy.

Outcomes: The outcomes evaluated were short and long-term maternal outcomes including pre-eclampsia, Caesarean section, future diabetes and other cardiovascular complications; and fetal outcomes including congenital anomalies, stillbirth, macrosomia, birth trauma, hypoglycemia and long-term effects.

Evidence: Published literature was retrieved through searches of PubMed and The Cochrane Library using appropriate controlled vocabulary (MeSH terms "diabetes" and "pregnancy"). Where appropriate, results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. There were no date limits but results were limited to English or French language materials.

Values: The quality of evidence was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care.

Summary statements: RECOMMENDATIONS.

Keywords: Diabetes; pregnancy; stillbirth.

Publication types

  • Practice Guideline

MeSH terms

  • Diabetes, Gestational* / diagnosis
  • Diabetes, Gestational* / therapy
  • Female
  • Humans
  • Mass Screening
  • Pregnancy
  • Pregnancy in Diabetics* / diagnosis
  • Pregnancy in Diabetics* / therapy
  • Preventive Health Services* / standards
  • Stillbirth / epidemiology